PMV Pharma Appoints Deepika Jalota, Pharm.D. as Senior Vice President and Head of Regulatory Affairs
as Senior Vice President and Head of Regulatory Affairs.
- as Senior Vice President and Head of Regulatory Affairs.
- Prior to joining PMV Pharma, Dr. Jalota was employed by Bayer HealthCare Pharmaceuticals beginning in July 2007 and was most recently Vice President, Global Regulatory Strategy Head, Oncology I.
- Dr. Jalota will lead the regulatory efforts for PMV Pharma's mutant p53 restoration drug pipeline drawing upon her experience leading global regulatory strategy for both early and late stage oncology therapeutics.
- PMV is advancing a pipeline of promising therapeutics that have the potential to improve the outcomes for patients with cancer.